Risk factors of long COVID 6–12 months after infection with the Omicron variant among nonhospitalized patients

药店 2019年冠状病毒病(COVID-19) 医学 大学医院 中国 临床药学 图书馆学 家庭医学 内科学 政治学 传染病(医学专业) 疾病 计算机科学 法学
作者
Guangting Zeng,Zanling Zhang,Linlin Wang,Jianqiang Li
出处
期刊:Journal of Medical Virology [Wiley]
卷期号:95 (11)
标识
DOI:10.1002/jmv.29235
摘要

Journal of Medical VirologyVolume 95, Issue 11 e29235 LETTER TO THE EDITOR Risk factors of long COVID 6–12 months after infection with the Omicron variant among nonhospitalized patients Guangting Zeng, Corresponding Author Guangting Zeng [email protected] orcid.org/0000-0001-6844-3949 Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, China Correspondence Guangting Zeng Email: [email protected]Search for more papers by this authorZanling Zhang, Zanling Zhang Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorLinlin Wang, Linlin Wang Department of Pharmacy, Cancer Center(Xiamen), Fudan University, Xiamen, ChinaSearch for more papers by this authorJianqiang Li, Jianqiang Li Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaSearch for more papers by this author Guangting Zeng, Corresponding Author Guangting Zeng [email protected] orcid.org/0000-0001-6844-3949 Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, China Correspondence Guangting Zeng Email: [email protected]Search for more papers by this authorZanling Zhang, Zanling Zhang Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaSearch for more papers by this authorLinlin Wang, Linlin Wang Department of Pharmacy, Cancer Center(Xiamen), Fudan University, Xiamen, ChinaSearch for more papers by this authorJianqiang Li, Jianqiang Li Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaSearch for more papers by this author First published: 06 November 2023 https://doi.org/10.1002/jmv.29235 Guangting Zeng and Zanling Zhang contributed equally to this study. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Luo J, Zhang J, Tang HT, et al. Prevalence and risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong. J Med Virol. 2023; 95:e28862. 10.1002/jmv.28862 CASPubMedWeb of Science®Google Scholar 2Xie Y, Choi T, Al-Aly Z. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study. BMJ. 2023; 381:e74572. Google Scholar 3Wang Y, Zhao D, Xiao W, et al. Paxlovid reduces the risk of long COVID in patients six months after hospital discharge. J Med Virol. 2023; 95:e29014. 10.1002/jmv.29014 CASPubMedWeb of Science®Google Scholar 4Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023; 21: 133-146. 10.1038/s41579-022-00846-2 CASPubMedWeb of Science®Google Scholar 5Nordström P, Ballin M, Nordström A. Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden. Lancet. 2022; 399: 814-823. 10.1016/S0140-6736(22)00089-7 PubMedWeb of Science®Google Scholar 6Ayoubkhani D, Bosworth ML, King S, et al. Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study. Open Forum Infect Dis. 2022; 9: c464. 10.1093/ofid/ofac464 Google Scholar 7Launay O, Cachanado M, Luong Nguyen LB, et al. Immunogenicity and safety of beta-adjuvanted recombinant booster vaccine. N Engl J Med. 2022; 387: 374-376. 10.1056/NEJMc2206711 PubMedWeb of Science®Google Scholar Volume95, Issue11November 2023e29235 ReferencesRelatedInformation
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
dery完成签到,获得积分10
1秒前
jjj完成签到,获得积分20
5秒前
fei完成签到,获得积分10
5秒前
6秒前
领导范儿应助xn201120采纳,获得10
7秒前
8秒前
yoon完成签到,获得积分20
9秒前
10秒前
10秒前
雷家发布了新的文献求助10
13秒前
科研通AI2S应助wlz采纳,获得10
14秒前
15秒前
douKY完成签到,获得积分0
15秒前
Rubisco发布了新的文献求助10
15秒前
16秒前
16秒前
Moonwalker_H完成签到 ,获得积分10
17秒前
ding应助AtticusFinch采纳,获得10
17秒前
yikeguozi完成签到,获得积分10
18秒前
19秒前
王京完成签到,获得积分10
21秒前
huche发布了新的文献求助10
21秒前
安陌煜完成签到,获得积分10
21秒前
华仔应助swbbb采纳,获得10
22秒前
Jasper应助自觉南风采纳,获得10
22秒前
tinydog完成签到,获得积分10
23秒前
慕青应助kx采纳,获得10
25秒前
锦鲤完成签到 ,获得积分10
28秒前
lotus_lee完成签到 ,获得积分10
30秒前
30秒前
31秒前
EVEN完成签到 ,获得积分10
31秒前
32秒前
geohr完成签到 ,获得积分10
34秒前
moodys完成签到,获得积分10
34秒前
ZhaoY完成签到,获得积分10
35秒前
长卿完成签到,获得积分10
35秒前
酷波er应助曾经可乐采纳,获得10
36秒前
李若灵完成签到,获得积分10
36秒前
自觉南风发布了新的文献求助10
36秒前
高分求助中
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3137814
求助须知:如何正确求助?哪些是违规求助? 2788675
关于积分的说明 7788104
捐赠科研通 2445088
什么是DOI,文献DOI怎么找? 1300139
科研通“疑难数据库(出版商)”最低求助积分说明 625828
版权声明 601043